Enoda Health

We push the boundary of what mobility data can do

Enoda brings the most extensively validated real-world mobility measurement ever built out of the research lab — and into the hands of the people who can use it to change lives.

The best mobility technology in the world shouldn’t sit on a shelf

For five years, more than 300 scientists and clinicians across 34 institutions built the algorithms, ran the trials and secured the regulatory support to make real-world mobility measurement work.
Enoda was founded to turn that work into a product — so the data can finally reach the people who need it.

Brought to you by the leaders of the groundbreaking Mobilise-D study

2019
Study launch
Mobilise-D study launched with the aim of developing validated measures of mobility.
2022
Technical validation
  • Algorithm development & technical validation complete
  • Two letters of support from the EMA
2024
Clinical validation
  • Data capture for c. 2,400 participants in clinical validation complete
  • SUSTAIN Mobilise-D launched
2026
Outcomes
  • Construct validity results
  • Ability to detect change
  • Predictive capacity
€50m
Over 5 years of research & trials
300+
Scientists, clinicians & industry experts
100+
Papers in leading journals
~2500
Participants in clinical trials

Three beliefs shape every decision we make

01
Mobility is a vital sign
Mobility is vitally important to people and a fundamental indicator of health.

Measuring it accurately and in real-world settings can provide data that is highly relevant and clinically meaningful.
02
Data quality shapes everything we do
We believe success is built on a foundation of great data.

Our methods and technology are designed with one goal in mind – generate the highest quality data for your study.
03
Usability is key
Part of data quality is having assessment methods that are feasible and technology that is easy to use.

We always strive to get a deep understanding of users (participants, clinicians, data scientists, sponsors, etc.) and incorporate their needs in our work.

Scientists, engineers & clinicians — many from Mobilise-D itself

Dr. Hugo Hiden
Co-Founder and Chief Technology Officer. Hugo was architect of the platform used to capture the data for the Mobilise-D study, and has led the development of Enoda’s Electronic Data Capture system.
Prof. Paul Watson
Co-Founder and Advisor. Paul is a leading expert on big data and analytics. He is a Professor of Computer Science at Newcastle University and former Director of the UK’s National Innovation Centre for Data.
Michael McMahon
Co-Founder and CEO. Michael has extensive experience in finance and strategy, and spent several years working in Deloitte as a strategy consultant.
Dr. Alison Keogh
Co-Founder and Advisor. Alison is an expert on participant needs specific to digital health solutions, and was the Patient and Public Involvement and Engagement (PPIE) lead in Mobilise-D.
Prof. Brian Caufield
Co-Founder and Advisor. Brian has extensive expertise in applying data driven technologies for better understanding of human health and behaviour. He led the data management workstream of Mobilise-D, and is the academic lead of the Sustain Mobilise-D project. Brian is also a PI in the Insight Centre for Data Analytics at UCD.
Dr. Felix Kluge
Co-Founder and Chief Data Officer. Felix specialises in turning real-world data into strategic insights and certified digital solutions. He played a key role in protocol and algorithm development in Mobilise-D and brings hands-on experience integrating digital endpoints into clinical trials at a global pharma company.
Carl Jackson
Co-Founder and Chief Commercial Officer. Carl founded and led SensL before selling the business to Onsemi. Carl is also an advisor to the venture capital firm Atlantic Bridge.
David Singleton
Co-Founder and Advisor. David has many years of experience in the technology and digital health sectors. He designed the integrated data capture solution for the Mobilise-D Technical and Clinical Validation Studies, and was responsible for the acquisition, storage, and access to, participant data.
Dr. Silvia Del Din
Co-Founder and Advisor. Silvia is an expert on digital health and the development and implementation of wearable technologies in clinical trials. She led the algorithm development workstream for Mobilise-D.
Dr. Lynn Rochester
Co-Founder and Advisor. Lynn is a leading authority in gait and mobility loss in neurodegenerative disease and ageing. Lynn was the Academic Lead for Mobilise-D

Read the work behind the product

Our team publishes whitepapers, methodology notes and regular updates on what we’re learning as Enoda reaches more cohorts. Everything is free and non paywalled.

Interested? Let’s talk

Whether you’re scoping a clinical trial or exploring mobility data in clinical care — we’d love to show you what Enoda can do with your cohort.